title: Quest for "innovative strategies" in primary PCI: clot busters or devices (protection vs suction) or both? A story in search of an end.
authors.forename: Pankaj
authors.initials: P
authors.lastname: Manoria
authors.forename: Vineet
authors.initials: V
authors.lastname: Malik
authors.forename: Suman
authors.initials: S
authors.lastname: Bhandari
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000379:methods* / Q000639:trends; D000925:Anticoagulants / Q000627:therapeutic use; D000077144:Clopidogrel; D023903:Coronary Restenosis / Q000188:drug therapy / Q000517:prevention & control*; D003331:Coronary Vessels / Q000473:pathology*; D004059:Diffusion of Innovation; D006629:Hirudins; D006801:Humans; D010446:Peptide Fragments / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D013923:Thromboembolism / Q000517:prevention & control*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; D000077144:Clopidogrel; D013988:Ticlopidine; C074619:bivalirudin